Chelsea Enright
Nurse Practitioner · Atlanta, GANPI 1831959964
Payments from drug & device makers
Across 74 payments — averaging $25.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$184
- E.r. Squibb & Sons, L.L.C.$173
- Incyte Corporation$133
- Pfizer$125
- Johnson & Johnson$94
- Takeda Pharmaceuticals U.S.A., Inc.$88
- plus $1K from 30 others
What the payments were for
- Food & beverage$1,871100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 7 | $184 |
| E.r. Squibb & Sons, L.L.C. | 4 | $173 |
| Incyte Corporation | 6 | $133 |
| Pfizer | 6 | $125 |
| Johnson & Johnson | 4 | $94 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $88 |
| GSK | 3 | $81 |
| Bayer | 3 | $78 |
| Genentech USA, Inc. | 3 | $59 |
| AbbVie | 2 | $53 |
| Stemline Therapeutics Inc. | 2 | $51 |
| Gilead(2 entities) | 2 | $50 |
| Deciphera Pharmaceuticals Inc. | 2 | $48 |
| Sumitomo Pharma America, Inc. | 2 | $44 |
| Servier Pharmaceuticals LLC | 2 | $43 |
| Pharmacosmos Therapeutics Inc. | 2 | $42 |
| Legend Biotech USA Inc. | 2 | $41 |
| Tersera Therapeutics LLC | 1 | $35 |
| Sanofi | 1 | $33 |
| Merck | 1 | $33 |
| Boehringer Ingelheim | 1 | $32 |
| Bristol Myers Squibb | 1 | $32 |
| Janssen Scientific Affairs, LLC | 1 | $30 |
| Springworks Therapeutics, Inc. | 1 | $28 |
| Novocure Inc. | 1 | $27 |
| Daiichi Sankyo Inc. | 1 | $26 |
| Acrotech Biopharma Inc. | 1 | $25 |
| Caris MPI, Inc. | 1 | $25 |
| Coherus Oncology, Inc. | 1 | $24 |
| Puma Biotechnology, Inc. | 1 | $23 |
| Sanofi-aventis U.S. LLC | 1 | $23 |
| Exelixis Inc. | 1 | $21 |
| Sobi, Inc | 1 | $20 |
| ADC Therapeutics America, Inc. | 1 | $19 |
| Karyopharm Therapeutics Inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $15 |
How this compares
$1,871 in reported general payments places this provider in the 80th percentile of 3,328 nurse practitioner providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other nurse practitioner in Atlanta
- Janice McAlisterAtlanta$241K
- Laura ElledgeAtlanta$177K
- Casey MillerAtlanta$41K
- Kathryn InanAtlanta$17K
- Colby DoepelAtlanta$16K
- Mark HebertAtlanta$15K
- Ashley BlackmonAtlanta$13K
- Alexia CovingtonAtlanta$13K
- Marissa TorresAtlanta$12K
- Hayley TurnerAtlanta$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.